Bain Capital Specialty Finance Prices $350M Senior Notes Offering Due 2031
BCSF is trading near its 52-week low of $13.2 (3.9% above the low).
Summary
Bain Capital Specialty Finance, Inc. finalized the pricing of its $350 million public offering of 5.950% senior notes due 2031, with proceeds intended for debt repayment and general corporate purposes.
Key Events · Financing and Capital Events · BCSF
-
Offering Priced
Bain Capital Specialty Finance, Inc. priced a public offering of $350 million aggregate principal amount of 5.950% senior notes due 2031.
-
Use of Proceeds
The company intends to use the net proceeds to repay outstanding secured indebtedness under its financing arrangements and for general corporate purposes.
-
Finalizes Prior Announcement
This filing finalizes the terms and pricing of the offering initially announced on January 22, 2026.
Analysis · BCSF · Unknown
This filing finalizes the terms for a substantial debt offering, representing a significant capital raise for Bain Capital Specialty Finance. The $350 million in senior notes will mature in 2031 and carry a 5.950% interest rate. The company plans to use the net proceeds to repay existing secured indebtedness and for general corporate purposes, which is a common strategy for managing capital structure and liquidity. This follows the initial announcement of the offering on January 22, 2026, and the pricing details disclosed in an FWP on January 23, 2026.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.7% of the 1013 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BCSF was trading at $13.71 on NYSE in the Unknown sector, with a market capitalization of approximately $889.3M. The 52-week trading range was $13.20 to $19.21. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.